Clinical Trial Update: E. Coli Nissle in Oncology [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Escherichia coli Nissle 1917 in gastric and colorectal cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Escherichia coli Nissle 1917 (Escherichia coli Nissle 1917)

Snippet

Sponsor: University of Hohenheim | Conditions: Gastric Cancer, Colorectal Cancer | Phase 3 | Status: COMPLETED